Skip to main content
Clinical Trials/ACTRN12619001020178
ACTRN12619001020178
Not yet recruiting
未知

A pilot study assessing the effectiveness of oral Propranolol in preventing epistasis in patients with Hereditary Haemorrhagic Telangiectasia.

Royal brisbane and Women's Hospital0 sites15 target enrollmentJuly 16, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Hereditary Haemorrhagic Telangiectasia
Sponsor
Royal brisbane and Women's Hospital
Enrollment
15
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 16, 2019
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Participants with a diagnosis of HHT according to curacao criteria score of \>4
  • Participants with an Epistaxis severity score of \>4 despite conventional treatment

Exclusion Criteria

  • Absolute contraindication to Propranolol e.g. Bradycardia
  • Pregnancy or breast feeding
  • Planned surgical intervention for epistaxis control
  • Deemed by cardiologist as unsuitable for taking Propranolol medication

Outcomes

Primary Outcomes

Not specified

Similar Trials